Torthaí cuardaigh - Oliver Floßmann

Beachtaigh na torthaí
  1. 1
    The long-term outcomes of systemic vasculitis

    The long-term outcomes of systemic vasculitis de réir Kerstin Westman, Oliver Floßmann, Gina Gregorini

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

    Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear de réir Michael Walsh, Alina Casian, Oliver Floßmann, Kerstin Westman, Peter Höglund, Charles D. Pusey, David Jayne

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage

    Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage de réir Aglaia Chalkia, Oliver Floßmann, Rachel Jones, Jagdish Nair, Thomas Simpson, Rona Smith, Lisa Willcocks, David Jayne

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Development of comprehensive disease assessment in systemic vasculitis

    Development of comprehensive disease assessment in systemic vasculitis de réir Oliver Floßmann, P. A. Bacon, Kirsten de Groot, David Jayne, Niels Rasmussen, Philip Seo, Kerstin Westman, Raashid Luqmani

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials

    Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials de réir Joanna Robson, Helen Doll, Ravi Suppiah, Oliver Floßmann, Lorraine Harper, Peter Höglund, David Jayne, Alfred Mahr, Kerstin Westman, Raashid Luqmani

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

    Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials de réir Joanna Robson, Helen Doll, Ravi Suppiah, Oliver Floßmann, Lorraine Harper, Peter Höglund, David Jayne, Alfred Mahr, Kerstin Westman, Raashid Luqmani

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

    Deoxyspergualin in relapsing and refractory Wegener's granulomatosis de réir Oliver Floßmann, Bo Baslund, Annette Bruchfeld, J. W. Cohen Tervaert, Cindy Hall, P Heinzel, Bernhard Hellmich, Raashid Luqmani, K Nemoto, Vladimı́r Tesař, David Jayne

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Long-term outcome of kidney function in patients with ANCA-associated vasculitis

    Long-term outcome of kidney function in patients with ANCA-associated vasculitis de réir Beatriz Sánchez‐Álamo, Laura Moi, Ingeborg M. Bajema, Annelies E. Berden, Oliver Floßmann, Zdenka Hrušková, David Jayne, Maria Wester-Trejo, Carin Wallquist, Kerstin Westman

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis

    Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis de réir Michael Walsh, Mikkel Faurschou, Annelies E. Berden, Oliver Floßmann, Ingeborg M. Bajema, Peter Höglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey, David Jayne

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse

    Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse de réir Matthew D. Morgan, Matthew Chak Hin Szeto, Michael Walsh, David Jayne, Kerstin Westman, Niels Henrik Rasmussen, Thomas F. Hiemstra, Oliver Floßmann, Annelies E. Berden, Peter Höglund, Lorraine Harper

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis de réir Bernhard Hellmich, Oliver Floßmann, W L Gross, P A Bacon, Jan Willem Cohen-Tervaert, L Guillevin, David Jayne, Alfred Mahr, Peter A. Merkel, Heiner Raspe, Dgi Scott, James Witter, Hasan Yazıcı, Raashid Luqmani

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

    Modification and validation of the Birmingham Vasculitis Activity Score (version 3) de réir Chetan Mukhtyar, R Lee, Denise Scott Brown, David Carruthers, Bhaskar Dasgupta, Shirish Dubey, Oliver Floßmann, Catherine Hall, J Hollywood, David Jayne, Rachel Jones, Peter Lanyon, Andrew J. Muir, David A. Scott, Lauren K. Young, Raashid Luqmani

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Explaining fatigue in ANCA-associated vasculitis

    Explaining fatigue in ANCA-associated vasculitis de réir Neil Basu, Andrew McClean, Lorraine Harper, E. Nicole Amft, Neeraj Dhaun, Raashid Luqmani, Mark A. Little, David Jayne, Oliver Floßmann, John McLaren, Винод Кумар, Lars P. Erwig, Donald Reid, Gary J. Macfarlane, Gareth T. Jones

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

    Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force de réir Chetan Mukhtyar, Oliver Floßmann, Bernhard Hellmich, Paul Bacon, María C. Cid, Jan Willem Cohen-Tervaert, Wolfgang L. Gross, Loı̈c Guillevin, David Jayne, Alfred Mahr, Peter A. Merkel, H. Raspe, David G. I. Scott, James Witter, Hasan Yazıcı, Raashid Luqmani

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis

    A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis de réir Ravi Suppiah, Chetan Mukhtyar, Oliver Floßmann, Federico Alberici, Bo Baslund, R.N. Batra, Denise Scott Brown, Julia U. Holle, Zdenka Hrušková, David Jayne, Andrew Judge, Mark A. Little, Anna Palmisano, Coen A. Stegeman, Vladimı́r Tesař, Augusto Vaglio, Kerstin Westman, Raashid Luqmani

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease

    Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease de réir Rachel Challis, Troels Ring, Yaobo Xu, Edwin Wong, Oliver Floßmann, Ian S. Roberts, Saeed Ahmed, Michael Wetherall, Giedrius Salkus, Vicky Brocklebank, Julian Fester, Lisa Strain, Valerie Wilson, Katrina Wood, Kevin J. Marchbank, Mauro Santibanez‐Koref, Timothy H.J. Goodship, David Kavanagh

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

    A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis de réir Ravi Suppiah, Andrew Judge, R.N. Batra, Oliver Floßmann, Lorraine Harper, Peter Höglund, M K Javaid, David Jayne, Chetan Mukhtyar, Kerstin Westman, John C. Davis, Gary S. Hoffman, W. Joseph McCune, Peter A. Merkel, E. William St. Clair, Philip Seo, Robert Spiera, John H. Stone, Raashid Luqmani

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines

    Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines de réir Joanna Tieu, Rona Smith, Neil Basu, Paul Brogan, David D’Cruz, Neeraj Dhaun, Oliver Floßmann, Lorraine Harper, Rachel Jones, Peter Lanyon, Raashid Luqmani, Stephen P. McAdoo, Chetan Mukhtyar, Fiona Pearce, Charles D. Pusey, Joanna Robson, Alan D. Salama, Lucy Smyth, Richard A. Watts, Lisa Willcocks, David Jayne

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

    Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature de réir David Kavanagh, Sarah McGlasson, Alexa Jury, J. Raymond Williams, Neil Scolding, Christopher Bellamy, Claudia Günther, Diane Ritchie, Daniel P. Gale, Yashpal S. Kanwar, Rachel Challis, Holly Buist, James Overell, Belinda Weller, Oliver Floßmann, Mark Blunden, Éric P. Meyer, Thomas Krucker, Stephen Evans, Iain L. Campbell, Andrew P. Jackson, Siddharthan Chandran, David Hunt

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring

    Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring de réir Meryl Waldman, María José Soler, Clara García-Carro, Liz Lightstone, Tabitha Turner‐Stokes, Megan Griffith, Joan Torrás, Laura Martínez Valenzuela, Oriol Bestard, Colin Geddes, Oliver Floßmann, Kelly Budge, Chiara Cantarelli, Enrico Fiaccadori, Marco Delsante, Enrique Morales, Eduardo Gutiérrez, José Antonio Niño-Cruz, Armando J. Martínez‐Rueda, Giorgia Comai, Claudia Bini, Gaetano La Manna, Maria Slon, Joaquín Manrique, Irene Agraz, Ninet Sinaii, Paolo Cravedi

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: